Medications for Transplantation Medicine Allograft Rejection Pediatric Liver And Small Bowel Measurement Of Donor And Thirdpartyinduced Cd154tcytotoxic Memory Cells Utilizing Whole Peripheral Blood Algorithm Reported As A Rejection Risk Score

1 result

  • everolimus

    (Everolimus)
    Ascend Laboratories, LLC
    Everolimus tablets are indicated for the prophylaxis of organ rejection in adult kidney transplant patients at low to moderate immunologic risk, in conjunction with basiliximab, cyclosporine, and corticosteroids. They are also used for liver transplant patients starting no sooner than 30 days post-transplant, alongside tacrolimus and corticosteroids.